Inhibrx Biosciences Inc
INBXLatest QuantConomy context for INBX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Inhibrx Biosciences Inc
QuantConomy has a structured record for INBX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- INBX
- Name
- Inhibrx Biosciences Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for INBX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| eps change | very bullish | 76 | May 14, 12:00 AM | INBX (Q1 2026, diluted eps): EPS grew 76.2% ($-9.04 → $-2.15). [sequential period basis, very bullish signal] |
| operating income change | very bullish | 76 | May 14, 12:00 AM | INBX (Q1 2026, operating income): grew 77.1% (-$135.03M → -$30.93M). [sequential period basis, very bullish signal] |
| net income change | very bullish | 76 | May 14, 12:00 AM | INBX (Q1 2026, net income): grew 76.1% (-$140.06M → -$33.44M). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| INBX | NASDAQ | alphavantage | Inhibrx Biosciences Inc |
| INBX | NASDAQ | alpaca | Inhibrx Biosciences, Inc. Common Stock |
| INBX | NASDAQ | fmp | Inhibrx Biosciences, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Vuori Kristiina MD | Insider | grant | 15,000 | — | — | 4 on EDGAR |
| Jun 3, 2026 | Kayyem Jon Faiz | Insider | grant | 15,000 | — | — | 4 on EDGAR |
| Jun 3, 2026 | MANHARD KIMBERLY | Insider | grant | 15,000 | — | — | 4 on EDGAR |
| Jun 3, 2026 | FORSYTH DOUGLAS | Insider | grant | 15,000 | — | — | 4 on EDGAR |
| Apr 24, 2026 | Matly David | President | grant | 50,000 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query INBX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access